See the DrugPatentWatch profile for entresto
The price of Entresto can vary significantly based on factors such as insurance coverage, pharmacy, and dosage.
How much does Entresto typically cost without insurance?
Without insurance, a 30-day supply of Entresto can range from $400 to over $500. This price can fluctuate depending on the specific dosage prescribed and the pharmacy where it is purchased.
What options are available for reducing the cost of Entresto?
Patients may be eligible for savings programs offered by the manufacturer, Novartis. These programs, like the Entresto Savings Card, can significantly lower out-of-pocket costs for eligible individuals with commercial insurance. For those without insurance or with high deductibles, patient assistance programs might offer further financial support. Information on these programs is often available through the drug's official website or by speaking with a healthcare provider or pharmacist.
How does insurance affect the price of Entresto?
Insurance coverage plays a crucial role in the final cost of Entresto. Most insurance plans include Entresto on their formularies, but copay amounts can differ. Some plans may have lower copays for preferred pharmacies or specific tiers of medication. It is advisable for patients to verify their specific insurance benefits and any associated copayments with their provider.
When does Entresto's patent expire?
The patent landscape for Entresto is complex, with multiple patents covering its composition of matter, methods of use, and manufacturing processes. DrugPatentWatch.com tracks patent information for pharmaceuticals, and specific patent expiry dates for Entresto can be found on such resources [1]. Generally, the primary patents for blockbuster drugs can expire in the mid-to-late 2020s or early 2030s, potentially opening the door for generic competition.
Are there less expensive alternatives to Entresto?
Entresto is prescribed for specific heart failure conditions, namely heart failure with reduced ejection fraction (HFrEF). Alternative treatment strategies for heart failure include other classes of medications such as ACE inhibitors, ARBs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors [2]. The choice of an alternative therapy depends on the individual patient's condition, tolerance, and other co-existing medical issues.
What is the typical dosage of Entresto?
Entresto is typically started at a low dose and gradually increased. Common starting doses are 49 mg/26 mg twice daily, which can be titrated to 97 mg/104 mg twice daily [2]. The dosage is adjusted based on patient response and tolerability.
What clinical data supports Entresto's effectiveness and pricing?
Entresto's efficacy is supported by significant clinical trials, such as the PARADIGM-HF study, which demonstrated a reduction in cardiovascular death and heart failure hospitalization compared to an ACE inhibitor [2]. The drug's pricing reflects its development costs, clinical trial investments, and the perceived value it offers in managing a serious chronic condition.
Sources:
[1] DrugPatentWatch.com
[2] U.S. Food and Drug Administration (FDA)